Free Trial

Orgenesis (ORGS) Competitors

Orgenesis logo
$1.10 +0.01 (+0.92%)
(As of 11/21/2024 ET)
No competitors for Orgenesis were found.

Get Orgenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORGS and its competitors with MarketBeat's FREE daily newsletter.

ORGS vs. The Competition

MetricOrgenesisPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$5.28M$6.51B$5.08B$8.84B
Dividend YieldN/A8.11%5.04%4.07%
P/E RatioN/A6.10101.1514.91
Price / Sales9.96366.291,209.4387.12
Price / CashN/A52.5939.5336.27
Price / Book-0.2210.186.926.35
Net Income-$55.36M$152.99M$118.58M$225.56M
7 Day PerformanceN/A-1.69%-1.42%-0.03%
1 Month Performance-32.10%-7.20%-3.31%2.00%
1 Year PerformanceN/A31.47%32.12%27.77%

Related Companies and Tools


This page (NASDAQ:ORGS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners